SCHOTT Pharma AG & Co KgaA
XETRA:1SXP

Watchlist Manager
SCHOTT Pharma AG & Co KgaA Logo
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
Watchlist
Price: 26.62 EUR 1.53% Market Closed
Market Cap: 4B EUR
Have any thoughts about
SCHOTT Pharma AG & Co KgaA?
Write Note

SCHOTT Pharma AG & Co KgaA
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

SCHOTT Pharma AG & Co KgaA
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
Total Equity
€690.4m
CAGR 3-Years
30%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
E
Evotec SE
XETRA:EVT
Total Equity
€968.5m
CAGR 3-Years
-1%
CAGR 5-Years
16%
CAGR 10-Years
20%
Gerresheimer AG
XETRA:GXI
Total Equity
€1.4B
CAGR 3-Years
16%
CAGR 5-Years
7%
CAGR 10-Years
11%
No Stocks Found

SCHOTT Pharma AG & Co KgaA
Glance View

Market Cap
4B EUR
Industry
Life Sciences Tools & Services

SCHOTT Pharma AG & Co KgaA is a DE-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Mainz, Hessen. The company went IPO on 2023-09-28. SCHOTT Pharma AG & Co. KGaA is a Germany-based Company, which designs advanced drug containment and drug delivery solutions for the pharmaceutical and biotech industries. The firm's product portfolio ranges from drug containment solutions to drug delivery systems manufactured in collaboration with industry partners. Its selection of pharmaceutical syringes, cartridges, vials, and ampoules is one of the widest and advanced on the market for injectable drugs.

1SXP Intrinsic Value
34.05 EUR
Undervaluation 22%
Intrinsic Value
Price

See Also

What is SCHOTT Pharma AG & Co KgaA's Total Equity?
Total Equity
690.4m EUR

Based on the financial report for Sep 30, 2023, SCHOTT Pharma AG & Co KgaA's Total Equity amounts to 690.4m EUR.

What is SCHOTT Pharma AG & Co KgaA's Total Equity growth rate?
Total Equity CAGR 3Y
30%

Over the last year, the Total Equity growth was -2%. The average annual Total Equity growth rates for SCHOTT Pharma AG & Co KgaA have been 30% over the past three years .

Back to Top